Low within- and between-day variability in exposure to new insulin glargine 300 U/ml

Lignende værker

• Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
  af: Steinstraesser, A, et al.
  Udgivet: (2014)
• Day-to-Day and Within-Day Variability in Glucose-Lowering Effect Between Insulin Degludec and Insulin Glargine (100 U/mL and 300 U/mL): A Comparison Across Studies
  af: Heise, Tim, et al.
  Udgivet: (2017)
• Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes
  af: Heise, Tim, et al.
  Udgivet: (2017)
• Insulin depot absorption modeling and pharmacokinetic simulation with insulin glargine 300 U/mL
  af: Lindauer, Klaus, et al.
  Udgivet: (2019)
• Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
  af: Kovatchev, Boris, et al.
  Udgivet: (2020)